CN Patent

CN119868550A — 缺氧诱导因子-脯酰胺羟基化酶抑制剂（hif-phi）在罕见贫血中的应用

Assigned to Kind Pharmaceutical LLC · Expires 2025-04-25 · 1y expired

What this patent protects

本申请涉及缺氧诱导因子‑脯酰胺羟基化酶抑制剂(HIF‑PHI)在罕见贫血中的应用。具体地，本申请公开了某些缺氧诱导因子‑脯酰胺羟基化酶抑制剂(HIF‑PHI)在治疗骨髓增生异常综合征贫血(MDS贫血)、β‑地中海贫血(β地贫)和/或镰状细胞疾病(镰刀型贫血、SCD贫血)中的应用。

USPTO Abstract

本申请涉及缺氧诱导因子‑脯酰胺羟基化酶抑制剂(HIF‑PHI)在罕见贫血中的应用。具体地，本申请公开了某些缺氧诱导因子‑脯酰胺羟基化酶抑制剂(HIF‑PHI)在治疗骨髓增生异常综合征贫血(MDS贫血)、β‑地中海贫血(β地贫)和/或镰状细胞疾病(镰刀型贫血、SCD贫血)中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN119868550A
Jurisdiction
CN
Classification
—
Expires
2025-04-25
Drug substance claim
No
Drug product claim
No
Assignee
Kind Pharmaceutical LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.